U.S. flag

An official website of the United States government

NM_001110792.2(MECP2):c.727G>A (p.Gly243Arg) AND not provided

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
May 17, 2016
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000726052.5

Allele description [Variation Report for NM_001110792.2(MECP2):c.727G>A (p.Gly243Arg)]

NM_001110792.2(MECP2):c.727G>A (p.Gly243Arg)

Gene:
MECP2:methyl-CpG binding protein 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xq28
Genomic location:
Preferred name:
NM_001110792.2(MECP2):c.727G>A (p.Gly243Arg)
Other names:
p.G231R:GGG>AGG; NM_001110792.2(MECP2):c.727G>A; p.Gly243Arg
HGVS:
  • NC_000023.11:g.154031137C>T
  • NG_007107.3:g.110967G>A
  • NM_001110792.2:c.727G>AMANE SELECT
  • NM_001316337.2:c.412G>A
  • NM_001369391.2:c.412G>A
  • NM_001369392.2:c.412G>A
  • NM_001369393.2:c.412G>A
  • NM_001369394.2:c.412G>A
  • NM_001386137.1:c.22G>A
  • NM_001386138.1:c.22G>A
  • NM_001386139.1:c.22G>A
  • NM_004992.4:c.691G>A
  • NP_001104262.1:p.Gly243Arg
  • NP_001303266.1:p.Gly138Arg
  • NP_001356320.1:p.Gly138Arg
  • NP_001356321.1:p.Gly138Arg
  • NP_001356322.1:p.Gly138Arg
  • NP_001356323.1:p.Gly138Arg
  • NP_001373066.1:p.Gly8Arg
  • NP_001373067.1:p.Gly8Arg
  • NP_001373068.1:p.Gly8Arg
  • NP_004983.1:p.Gly231Arg
  • NP_004983.1:p.Gly231Arg
  • LRG_764t1:c.727G>A
  • LRG_764t2:c.691G>A
  • LRG_764:g.110967G>A
  • LRG_764p1:p.Gly243Arg
  • LRG_764p2:p.Gly231Arg
  • NC_000023.10:g.153296588C>T
  • NC_000023.10:g.153296588C>T
  • NG_007107.2:g.110991G>A
  • NM_004992.3:c.691G>A
Protein change:
G138R
Links:
dbSNP: rs587783139
NCBI 1000 Genomes Browser:
rs587783139
Molecular consequence:
  • NM_001110792.2:c.727G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001316337.2:c.412G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001369391.2:c.412G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001369392.2:c.412G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001369393.2:c.412G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001369394.2:c.412G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001386137.1:c.22G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001386138.1:c.22G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001386139.1:c.22G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_004992.4:c.691G>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000191044GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Uncertain significance
(Apr 14, 2016)
germlineclinical testing

Citation Link,

SCV000341519Eurofins Ntd Llc (ga)
criteria provided, single submitter

(EGL Classification Definitions 2015)
Uncertain significance
(May 17, 2016)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknown1not providednot providednot providednot providedclinical testing

Details of each submission

From GeneDx, SCV000191044.12

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The G231R variant was identified previously in a female with seizures and intellectual and developmental disabilities; however, no additional information was provided to unequivocally demonstrate that it is pathogenic and parental studies were not performed (Sundaram et al., 2014). It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The G231R variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved in mammals, and missense variants in a nearby residue (P225R, P225T) have been reported in RettBASE and the Human Gene Mutation Database in association with Rett syndrome (MECP2 Variation Database; Stenson et al., 2014). However, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Eurofins Ntd Llc (ga), SCV000341519.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided1not providednot providednot provided

Last Updated: Nov 10, 2024